TrialBritish journal of cancer2014

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma.

A B El-Khoueiry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.